Franco, R., et al., The central role of glutathione in the pathophysiology of human diseases
Autoimmunity, Inflammation, and Dysbiosis Mutually Govern the Transition from the Preclinical to the Clinical Stage of Rheumatoid Arthritis
Canadian and global data, including NEJM 2023, show bigger weight loss, sharper insulin peaks, and better lipid profiles than single-agonist peptides
This means that fewer pain signals reach the brain, so we feel less pain
2025 marked major milestones in CNS drug development, with multi-billion-dollar partnerships including AbbVie/Gilgamesh, Novartis/Avidity and Roche/Manifold highlighting robust investment across numerous therapeutic areas
Future Research Directions Ongoing research aims to better understand the long-term effects of PT 141, optimal dosing strategies, and its application in broader populations